DALPICICLIB

Search structure
Synonyms:
Status: Phase 2
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 5ZHA5P4PFX

Structure
InChI Key SGJLSPUSUBJWHO-UHFFFAOYSA-N
Smile CC(=O)c1c(C)c2cnc(Nc3ccc(C4CCNCC4)cn3)nc2n(C2CCCC2)c1=O
InChI
InChI=1S/C25H30N6O2/c1-15-20-14-28-25(29-21-8-7-18(13-27-21)17-9-11-26-12-10-17)30-23(20)31(19-5-3-4-6-19)24(33)22(15)16(2)32/h7-8,13-14,17,19,26H,3-6,9-12H2,1-2H3,(H,27,28,29,30)

Physicochemical Descriptors

Property Name Value
Molecular Formula C25H30N6O2
Molecular Weight 446.56
AlogP 4.02
Hydrogen Bond Acceptor 8.0
Hydrogen Bond Donor 2.0
Number of Rotational Bond 5.0
Polar Surface Area 101.8
Molecular species BASE
Aromatic Rings 3.0
Heavy Atoms 33.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase CMGC protein kinase group
- 10 - - -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Breast Neoplasms 3 D001943 ClinicalTrials
Breast Neoplasms 3 D001943 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Esophageal Neoplasms 2 D004938 ClinicalTrials
Carcinoma, Squamous Cell 2 D002294 ClinicalTrials
Sarcoma 2 D012509 ClinicalTrials
Ovarian Neoplasms 2 D010051 ClinicalTrials
Nasopharyngeal Carcinoma 2 D000077274 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Melanoma 1 D008545 ClinicalTrials
Liver Diseases 1 D008107 ClinicalTrials
Stomach Neoplasms 1 D013274 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4802161
FDA SRS 5ZHA5P4PFX
CONTENTS